Out-of-the-Box Solutions for Building Clinical Capacity in Community Settings to

Improve Standardized ERBB2 (HER2) Testing in NSCLC

Congratulations!

You’ve taken the first step for you and your practice to achieve measurable changes that will ensure your infrastructure and processes are optimized to support guideline‑driven biomarker testing, individualized treatment, and coordination of care for patients with advanced NSCLC.

Using this simple, systematic approach to quality improvement, intended for easy access and application in any practice setting, you will have the framework and tools you need to drive changes that positively impact care for your patients. Let’s get started!

Participate in digital QI

This digital QI is designed to be effective and as easy as 1-2-3

1

Assess

To assess possible areas of improvement, you will complete an assessment that asks to what extent you or your practice:

  • Assesses all recommended biomarkers with multigene panel testing
  • Incorporates multidisciplinary workflows and processes for tissue collection, biomarker testing, and biomarker test interpretation
  • Implements protocols and procedures for biomarker testing using either in-house or outside labs
  • Integrates biomarker testing protocols and results with your electronic health record
  • Introduces workflows to reduce biomarker test turnaround times
  • Establishes multidisciplinary frameworks to interpret biomarker test results prior to initiation of systemic therapy
  • Implements guideline-directed therapy for patients with ERBB2-altered advanced/metastatic NSCLC Embeds treatment algorithms and protocols for advanced/metastatic NSCLC and actionable ERBB2 alterations within the electronic health record

You will receive a report card that summarizes your or your practice's performance relative to areas assessed. This serves as your baseline and guides development of your personalized action items.

2

Implement in Practice

Working with our expert faculty, we followed a Model for Improvement that outlines the aims of this program and its . We provide educational and practical interventions, but you can develop your own to meet your specific needs. Depending on your baseline assessment, interventions you can implement include:

  • Enhanced training
  • Communication strategies
  • Personalized action items to track based on the nuanced needs of your practice
  • Patient education
3

Re-assess

Once you’ve finished the interventions and have introduced the recommended process changes, it's time to put them to the test!

  • Return to this digital QI portal after a minimum of
  • Re-assess your action plan to see what improvements were realized
  • Complete a personal reflection
  • Get your certificate

We recommend you share these findings with key stakeholders in your organization to reflect on ongoing improvements and/or future opportunities.

Faculty

Christine Bestvina, MD Assistant Professor of Medicine
Section of Hematology/Oncology
University of Chicago Department of Medicine
Chicago, IL
Melissa Tjota, MD, PhD Assistant Professor
Department of Pathology
University of Chicago Medicine

Not interested in participating in this digital QI but want to view our tools and resources?

Access the Toolkit